Ann: Chinese Approval of First Cosmetic Product, page-12

Haven't followed JAT previously to know all the ins-outs but since buying in and adding some here and there one gets the sense that JAT is rather underrated currently. With an MC at only around $36mill, one has to ask the question - is this sidelined by the markets and if so why? Judging from the increasing sales channels in multiple countries and an increasing product range and increased manufacturing capability appears to indicate huge upside potential.

Guessing the markets look at JAT's debt position coupled with the downturn due to the unfortunate pandemic and view JAT with a high degree of risk. From what I can ascertain though, is that as market penetration gains traction with more sales opportunities, it is a matter of time when JAT will be reevaluated by the markets and as a result hopefully a rerate is coming.

Also guessing markets are waiting for the quarterly results and commentary going forward as can be evidenced by SP hovering around current levels and if today's announcement is anything to go by, markets may be pleasingly surprised once those figures are released and react accordingly.

Guess we'll know soon enough whether the guessing is guessed correctly or else, not.